Novartis gene therapy poised to expand SMA treatment landscape – Healthcare News
Novartis has recently announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) successfully achieved the primary endpoint in...
Novartis has recently announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) successfully achieved the primary endpoint in...
AUSTIN, Texas, Jan. 6, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on...
Dublin, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The "CRISPR-based Gene Editing Market Size, Share and Trends Analysis Report by Product...
Gene Therapy Products MarketThe Gene Therapy Products Market sector is undergoing significant transformation, with substantial growth and technological advancements expected...
Hundreds of NHS England (NHSE) patients are set to benefit from access to the first gene therapy in Europe for...
Emerging novel cell and gene therapies allow for the possibility of untethering patients from a lifetime of burdensome, costly chronic...
For years, one medical technology has captivated the scientific community: CRISPR. In 2012, Emmanuelle Charpentier, a microbiologist, geneticist and biochemist,...
Casgevy has been approved for treating sickle cell disease and transfusion-dependent beta thalassemia patients aged 12 and older in the...
Around the turn of the century, microbiologists at Danisco USA Inc. had a problem: The bacteria they used to make...